60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. (SXTP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SXTP · as of Jun 8, 2026
Key Statistics
Explore 60 Degrees Pharmaceuticals, Inc. Data
sxtp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
sxtp competitorsSXTP
BDRX
CANF
CLDI
CMND
CNSPStock Performance
Full HistoryAbout 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United Stat…
what is 60 degrees pharmaceuticals, inc. · sxtp stock overview · 60 degrees pharmaceuticals, inc. company profile · who is 60 degrees pharmaceuticals, inc. ceo · sxtp NASDAQ · 60 degrees pharmaceuticals, inc. headquarters · 60 degrees pharmaceuticals, inc. business segments
About Stock Overview & Key Data
60 Degrees Pharmaceuticals, Inc. (SXTP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 12, 2023. As of the latest trading session, SXTP stock price is $1.43, with a market capitalization of $1.2M. The stock has returned -87.67% over the past 12 months and -29.56% year-to-date.
According to 2 Wall Street analysts, the consensus rating for 60 Degrees Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, 60 Degrees Pharmaceuticals, Inc. reported revenue of $1.0M and net income of -$7.4M. For detailed data — including 60 Degrees Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, 60 Degrees Pharmaceuticals, Inc. (SXTP) stock price is $1.43. The stock is traded on NASDAQ under the ticker symbol SXTP. The 52-week range is $1.29 – $12.96.